C-peptide and Its Role in Type 1 Diabetes
Author Information
Author(s): Anders A. F. Sima, George Grunberger, Hans Jörnvall, John Wahren
Primary Institution: Wayne State University
Hypothesis
What are the physiological effects and potential therapeutic value of C-peptide replacement in type 1 diabetes?
Conclusion
C-peptide replacement may prevent and improve chronic complications in type 1 diabetes, particularly diabetic neuropathy and nephropathy.
Supporting Evidence
- C-peptide replacement has been shown to improve nerve function in type 1 diabetes patients.
- C-peptide can stimulate Na+, K+-ATPase activity, which is important for nerve and kidney function.
- Clinical studies indicate that C-peptide may reduce urinary albumin excretion in diabetic patients.
Takeaway
C-peptide is a part of insulin that helps with diabetes, and giving it to people with type 1 diabetes can help them feel better and avoid problems.
Methodology
The study reviews cellular, physiological, and clinical effects of C-peptide replacement in animal models and patients with type 1 diabetes.
Limitations
The exact mechanisms of C-peptide's effects and its interactions with insulin and other hormones are not fully understood.
Want to read the original?
Access the complete publication on the publisher's website